Candidate gene studies of ADHD: a meta-analytic review.

Department of Genetics, University of North Carolina at Chapel Hill, 120 Mason Farm Road, Room 5015 Genetic Medicine Building CB 7264, Chapel Hill, NC 27599-7264, USA.
Human Genetics (Impact Factor: 4.52). 07/2009; 126(1):51-90. DOI: 10.1007/s00439-009-0694-x
Source: PubMed

ABSTRACT Quantitative genetic studies (i.e., twin and adoption studies) suggest that genetic influences contribute substantially to the development of attention deficit hyperactivity disorder (ADHD). Over the past 15 years, considerable efforts have been made to identify genes involved in the etiology of this disorder resulting in a large and often conflicting literature of candidate gene associations for ADHD. The first aim of the present study was to conduct a comprehensive meta-analytic review of this literature to determine which candidate genes show consistent evidence of association with childhood ADHD across studies. The second aim was to test for heterogeneity across studies in the effect sizes for each candidate gene as its presence might suggest moderating variables that could explain inconsistent results. Significant associations were identified for several candidate genes including DAT1, DRD4, DRD5, 5HTT, HTR1B, and SNAP25. Further, significant heterogeneity was observed for the associations between ADHD and DAT1, DRD4, DRD5, DBH, ADRA2A, 5HTT, TPH2, MAOA, and SNAP25, suggesting that future studies should explore potential moderators of these associations (e.g., ADHD subtype diagnoses, gender, exposure to environmental risk factors). We conclude with a discussion of these findings in relation to emerging themes relevant to future studies of the genetics of ADHD.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Trait theories of leadership have documented the role of individual characteristics in affecting leadership. Twin studies have further revealed significant genetic effects on leadership role occupancy. In the era of genomics, the current research examines how a dopamine transporter gene, DAT1, is involved in genetic influences on leadership role occupancy. Study 1 found DAT1 10-repeat allele to negatively relate to proactive personality, which in turn was positively associated with leadership role occupancy. The negative indirect effect was significant, but the overall relationship between this gene and leadership was not. In addition to replicating Study 1's findings using a nationally representative sample, Study 2 revealed another countervailing mechanism: DAT1 was positively related to (moderate) rule breaking, which was positively associated with leadership role occupancy. Consistent findings across the two studies suggest that the pathways linking specific genes to leadership are complex and a middle-ground approach is needed in such multidisciplinary investigations.
    The Leadership Quarterly 01/2015; · 2.70 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In het alledaagse taalgebruik zijn psychiatrische diagnoses uniforme categorieën geworden: iemand heeft ADHD en behoort daarmee tot de homogeen voorgestelde groep ‘ADHD’ers’. Categorische psychiatrische diagnostiek is weliswaar een noodzakelijkheid om met elkaar van gedachten te kunnen wisselen over de problematiek maar suggereert ook een uniformiteit waarachter aanzienlijke interindividuele verschillen schuil kunnen gaan. Juist die heterogeniteit maakt het moeilijk gericht onderzoek te doen naar de neurobiologische oorzaken van verschillende stoornissen. Dit artikel behandelt hoe theorievorming over en empirisch onderzoek naar heterogeniteit in de neurobiologie van aandachtstekortstoornis met hyperactiviteit (Attention-Deficit/Hyperactivity Disorder,of ADHD) ons dichter bij de oorzaken ervan zou kunnen brengen. Hiervoor worden studies gebruikt uit het proefschrift van de auteur en werk van andere onderzoeksgroepen. Het betreft vooral studies bij kinderen en adolescenten met ADHD maar de bespreking kan zeker geëxtrapoleerd worden naar ADHD bij volwassenen. Abstract Background.The dichotomous diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) suggests a homogeneous clinical and etiological entity. In reality, much variation between patients is commonly found, both clinically as well as in neurobiological and neuropsychological studies.Method. This article discusses how neurobiological and neuropsychological heterogeneity may be a specific target of research. Both research into brain development and neuropsychology in ADHD is addressed.Results. First, an example is given of how results of genetic studies on the ADHD-IQ relationship can lead to hypotheses on differential brain development in ADHD in low versus high IQ. Next, neuropsychological heterogeneity is addressed. Separate brain systems are involved in separable aspects of cognition that may be affected in ADHD. Based on the large body of neuropsychological work to date, multiple authors have suggested that not all brain systems implicated in ADHD (and the cognitive functions they support) should necessarily be affected in all patients with the disorder. A number of studies investigating such neuropsychological heterogeneity are discussed. Finally, etiological heterogeneity is briefly addressed: several causative factors may affect changes in brain and cognition in ADHD in concert or in interaction.Conclusions. Inconsistencies in the neurobiological literature on ADHD may arise in part because the heterogeneity that can be expected in the underlying neurobiology is not acknowledged. For example, by studying more neurobiologically homogeneous subgroups, research may be better able to target separable developmental pathways towards ADHD.
    Neuropraxis. 08/2012; 16(3):79-86.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Attention-deficit hyperactivity disorder (ADHD) is estimated to affect 8-12% of school-age children worldwide. ADHD is a complex disorder with significant genetic contributions. However, no single gene has been linked to a significant percentage of cases, suggesting that environmental factors may contribute to ADHD. Here, we used behavioral, molecular, and neurochemical techniques to characterize the effects of developmental exposure to the pyrethroid pesticide deltamethrin. We also used epidemiologic methods to determine whether there is an association between pyrethroid exposure and diagnosis of ADHD. Mice exposed to the pyrethroid pesticide deltamethrin during development exhibit several features reminiscent of ADHD, including elevated dopamine transporter (DAT) levels, hyperactivity, working memory and attention deficits, and impulsive-like behavior. Increased DAT and D1 dopamine receptor levels appear to be responsible for the behavioral deficits. Epidemiologic data reveal that children aged 6-15 with detectable levels of pyrethroid metabolites in their urine were more than twice as likely to be diagnosed with ADHD. Our epidemiologic finding, combined with the recapitulation of ADHD behavior in pesticide-treated mice, provides a mechanistic basis to suggest that developmental pyrethroid exposure is a risk factor for ADHD.-Richardson, J. R., Taylor, M. M., Shalat, S. L., Guillot III, T. S., Caudle, W. M., Hossain, M. M., Mathews, T. A., Jones, S. R., Cory-Slechta, D. A., Miller, G. W. Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder. © FASEB.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 01/2015;


1 Download
Available from